Lactate Dehydrogenase as a New Prognostic Factor for Mortality in Multisystem Inflammatory Syndrome in Children
Publish place: International Journal of Pediatrics، Vol: 12، Issue: 0
Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: English
View: 13
This Paper With 10 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_INJPM-12-0_004
تاریخ نمایه سازی: 30 مرداد 1403
Abstract:
Background: Multisystem Inflammatory Syndrome in Children (MIS-C) is a rather newly described entity that can potentially end in multisystem failure in children following COVID-۱۹ infection. The prognosis of patients with MIS-C is multifactorial; consequently, many risk factors increase the risk of mortality and severity of this disease. In this study we aimed to evaluate the prognostic effect of various parameters in mortality and intensive care unit admission of patients with MIS-C. Methods: in this cross-sectional study, the information of patients with MIS-C were extracted in a tertiary pediatric center during a one-year period. The relationship between mortality and ICU admission of the patients with demographic information and lab data were assessed. Results: a total of ۸۸ male-predominant (۵۶.۸% vs. ۴۳.۲%, P=۰.۱۳۵) entered the study. Seven patients had expired and ۷۱ patients were discharged from the hospital. In our study, demographic information of the patients and their lab data were not associated with mortality except for Lactate Dehydrogenase (LDH) level. All of the expired patients had elevated LDH, while only ۵۳.۱% of the discharged patients showed increased LDH (P=۰.۰۱۶); on the other hand, LDH did not differ between patients who were managed in ICUs and the ones who were managed in wards. Conclusion: LDH can be counted as a prognostic tool for mortality in MIS-C and might be regarded as a part of evaluation for ICU admission in this disease.
Authors
Aida Askarisarvestani
Division of Allergy and Clinical Immunology, Department of Pediatrics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Seyed Hesamedin Nabavizadeh
Department of Pediatrics,Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Mina Esmailli
Department of Pediatrics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Soheila Alyasin
Department of Allergy and Clinical Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
Hossein Esmaeilzadeh
Department of Pediatrics,Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :